ANTI-STEAP1 ANTIGEN-BINDENDES PROTEIN

European patent · EP3817770 · In force

Register entry

Publication number
EP3817770
Application number
EP19745402
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 2, 2019
Published
May 12, 2021
Granted
May 6, 2026
Protection ends at the latest
Jul 1, 2039
Next annual fee due
Jul 31, 2027
IPC classes
C07K 16/18 (2006.01)
A61K 39/12 (2006.01)
A61K 39/00 (2006.01)
A61K 40/11 (2025.01)
A61K 40/42 (2025.01)
A61P 13/08 (2006.01)
A61P 35/00 (2006.01)
Priority
US 201862693216 P 02.07.2018
US 201962800259 P 01.02.2019
PCT application
PCT/US2019/040296 02.07.2019
PCT publication
WO2020/010079 09.01.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. May 6, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 06.05.2026

Parties

Inventor

NOLAN-STEVAUX, Olivier

Thousand Oaks, CA 91320-1799, US

LI, Cong

Thousand Oaks, CA 91320-1799, US

MURAWSKY, Christopher, M.

Thousand Oaks, CA 91320-1799, US

ALBA, Benjamin, M.

Thousand Oaks, CA 91320-1799, US

AGRAMAL, Neeraj Jagdish

Thousand Oaks, CA 91320-1799, US

GRAHAM, Kevin

Thousand Oaks, CA 91320-1799, US

STEVENS, Jennitte, LeAnn

Thousand Oaks, CA 91320-1799, US

MOORE, Gregory

Monrovia, CA 91016, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.